Filing Details

Accession Number:
0000929638-23-002356
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-25 16:25:02
Reporting Period:
2023-08-23
Accepted Time:
2023-08-25 16:25:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588972 Societal Cdmo Inc. SCTL Pharmaceutical Preparations (2834) 261523233
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1600004 First Light Asset Management, Llc 3300 Edinborough Way
Suite 201
Edina MN 55435
No No No No
1991162 Paul Mathew Arens C/O First Light Asset Management, Llc
3300 Edinborough Way, Suite 201
Edina MN 55435
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-24 6,250,000 $0.40 19,676,396 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2023-08-23 20,000 $0.00 20,000 $0.61
Common Stock Pre-Funded Warrant (right to buy) Acquisiton 2023-08-24 1,250,000 $0.40 125,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2033-08-23 No 4 A Direct
125,000 2023-08-24 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 635,000 Direct
Footnotes
  1. Represents shares held for the benefit of private investment vehicles (the "Accounts") for which First Light Asset Management, LLC ("First Light") serves as investment adviser. Mr. Arens is the Managing Member, CEO and Senior Portfolio Manager of First Light. In such capacities, the Reporting Persons may be deemed to beneficially own securities held for the benefit of the Accounts. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of his or its pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  2. Stock options granted to Mr. Arens in his capacity as a director of the Issuer. Stock option vests in three equal annual installments, beginning on August 23, 2024, subject to Mr. Aren's continuous service with the Issuer.
  3. Held jointly by Mr. Arens and his wife. The warrant has no expiration date. Under its terms, the warrant may be converted to Common Stock only to the extent that such conversion would not cause (i) the holder itself to beneficially own in excess of 0.99% of the shares of Common Stock then outstanding or (ii) the holder, together with its affiliates and any other person or entity acting as a group, to beneficially own in excess of 19.95% of the shares of Common Stock then outstanding.